The Cost-Effectiveness of Congenital Adrenal Hyperplasia Newborn Screening in Brazil: A Comparison Between Screened and Unscreened Cohorts

Background: Newborn screening for congenital adrenal hyperplasia (CAH-NBS) is not yet a worldwide consensus, in part due to inconclusive evidence regarding cost-effectiveness because the analysis requires an understanding of the short- and long-term costs of care associated with delayed diagnosis. O...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Front Pediatr
Auteurs principaux: de Miranda, Mirela Costa, Haddad, Luciana Bertocco de Paiva, Trindade, Evelinda, Cassenote, Alex, Hayashi, Giselle Y., Damiani, Durval, Costa, Fernanda Cavalieri, Madureira, Guiomar, de Mendonca, Berenice Bilharinho, Bachega, Tania A. S. S.
Format: Artigo
Langue:Inglês
Publié: Frontiers Media S.A. 2021
Sujets:
Pediatrics
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC8183606/
https://ncbi.nlm.nih.gov/pubmed/34109139
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fped.2021.659492
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires